Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Wang WX, Spiegelman D, Rao PK, Rhee RL, Ford AL, Miner JJ, Apte RS. J Clin Invest. 2024 Dec 16;134(24):e189023. doi: 10.1172/JCI189023. PMID: 39680465